Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Working Capital Changes (2021 - 2023)

Historic Other Working Capital Changes for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $13.6 million.

  • ADC Therapeutics' Other Working Capital Changes rose 1894.26% to $13.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.4 million, marking a year-over-year decrease of 3552.86%. This contributed to the annual value of -$6.9 million for FY2024, which is 19369.5% down from last year.
  • Latest data reveals that ADC Therapeutics reported Other Working Capital Changes of $13.6 million as of Q4 2023, which was up 1894.26% from -$1.3 million recorded in Q3 2023.
  • ADC Therapeutics' Other Working Capital Changes' 5-year high stood at $13.6 million during Q4 2023, with a 5-year trough of -$4.3 million in Q2 2023.
  • Its 5-year average for Other Working Capital Changes is $1.4 million, with a median of -$1759.0 in 2021.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 38724998.31% in 2022, then tumbled by 8827359.11% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Other Working Capital Changes stood at $1804.0 in 2019, then skyrocketed by 79168.29% to $1.4 million in 2020, then tumbled by 100.21% to -$2961.0 in 2021, then surged by 387249.98% to $11.5 million in 2022, then rose by 18.94% to $13.6 million in 2023.
  • Its Other Working Capital Changes was $13.6 million in Q4 2023, compared to -$1.3 million in Q3 2023 and -$4.3 million in Q2 2023.